v3.25.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
REVENUES $ 643 $ 2,541 $ 2,305 $ 6,698
COST OF REVENUES 460 798 1,566 2,792
GROSS PROFIT 183 1,743 739 3,906
OPERATING EXPENSES:        
Research and development expenses 591 543 1,947 1,793
Sales and marketing expenses 789 727 2,155 2,001
General and administrative expenses 805 790 2,224 2,398
Other income (73)   (73) (163)
TOTAL OPERATING EXPENSES 2,112 2,060 6,253 6,029
OPERATING LOSS (1,929) (317) (5,514) (2,123)
Interest expense (27) (246) (83) (590)
Other Financial income (expense), net (24) 52 (144) 138
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,980) $ (511) $ (5,741) $ (2,575)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.17) $ (0.09) $ (0.58) $ (0.59)
Net loss per share attributable to common shareholders – diluted (in Dollars per share) $ (0.17) $ (0.09) $ (0.58) $ (0.59)
Weighted average number of common stocks used in computing net loss per share – basic (in Shares) 11,787,617 6,014,548 9,824,867 4,429,738
Weighted average number of common stocks used in computing net loss per share – diluted (in Shares) 11,787,617 6,014,548 9,824,867 4,429,738

Source